aTYR PHARMA (ATYR) Other Accumulated Expenses (2014 - 2025)

aTYR PHARMA (ATYR) has 12 years of Other Accumulated Expenses data on file, last reported at $844000.0 in Q4 2025.

• Quarterly Other Accumulated Expenses rose 9.75% year-over-year to $844000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $844000.0 (up 9.75% YoY) and the FY2025 annual result came in at $844000.0, up 9.75% from the prior year.
• Other Accumulated Expenses rose to $844000.0 in Q4 2025, from $769000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.9 million in Q4 2022 to a low of $672000.0 in Q4 2021.
• A 5-year average of $1.1 million and a median of $844000.0 in 2025 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 187.2% — and 2023, when it slumped 43.01%.
• Tracing ATYR's Other Accumulated Expenses over 5 years: stood at $672000.0 in 2021, then jumped by 187.2% to $1.9 million in 2022, then tumbled by 43.01% to $1.1 million in 2023, then plunged by 30.09% to $769000.0 in 2024, then advanced by 9.75% to $844000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $844000.0 (Q4 2025), $769000.0 (Q4 2024), and $1.1 million (Q4 2023), per Business Quant data.